Local delivery of enoxaparin to decrease restenosis after stenting: Results of initial multicenter trial. Polish-American local lovenox NIR assessment study (the POLONIA study)

Circulation

Volumn 103, Issue 1, 2001, Pages 26-31

  Kiesz, R Stefan ^a,b   Buszman, Pawel ^c   Martin, Jack L ^d   Deutsch, Ezra ^e   Rozek, M Marius ^b   Gaszewska, Ewa ^c   Rewicki, Marek ^f   Seweryniak, Piotr ^g   Kosmider, Maciej ^h   Tendera, Michal ^c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d Department of Cardiology   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f INSTITUTE OF CARDIOLOGY   (Poland)

^g Ministry of Interior and Administration Republic of Poland Central Clinical Hospital   (Poland)

^h Faculty of Medicine   (Poland)

Author keywords

Coronary disease; Drug delivery systems; Enoxaparin; Stents

Indexed keywords

ENOXAPARIN; HEPARIN;

ADULT; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DRUG DELIVERY SYSTEM; FEMALE; FOLLOW UP; HEPARINIZATION; HUMAN; IMPLANTATION; MALE; MITOSIS INHIBITION; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; SMOOTH MUSCLE FIBER;

EID: 0035830416     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.1.26     Document Type: Article

References (50)

1. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group
2. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators
3. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
4. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization
5. Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis
6. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil
7. Coronary stenting with a novel stainless steel balloon-expandable stent: Determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model
8. A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies
9. Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF
10. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit
11. Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries
12. Local catheter-based intracoronary radiation therapy for restenosis
13. Pathology of acute and chronic coronary stenting in humans
14. Effects of endovascular radiation from a β-particle-emitting stent in a porcine coronary restenosis model: A dose-response study
15. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
16. Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty: Results of the Beta Energy Restenosis Trial (BERT)
17. Rationale for local drug delivery
18. Prospects for site-specific delivery of pharmacologic and molecular therapies
19. Use of locally delivered conventional drug therapies
20. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
21. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
22. Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results
23. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits
24. The Heparin Infusion Prior to Stenting (HIPS) Trial: Procedural, in-hospital, 30 day, and six month clinical, angio-graphic and IVUS results
25. Antisense oligonucleotide against c-myc administered with the transport delivery catheter for the prevention of in-stent restenosis: Results of the randomized ITALICS Trial
26. Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions
27. Proliferative response of human and minipig smooth muscle cells after coronary angioplasty to growth factors and platelets
28. Heparin-induced over-expression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells
29. Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation
30. Enoxaparin suppresses thrombin formation and activity during cardiopulmonary bypass in baboons
31. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins
32. Inhibition of intimal hyperplasia and occlusion in Dacron graft with heparin and low molecular weight heparin
33. Feasibility and efficacy of locally delivered enoxaparin via the channeled balloon catheter on smooth muscle cell proliferation following balloon injury in rabbits
34. Low molecular weight heparin in prevention of restenosis after angioplasty: Results of Enoxaparin Restenosis (ERA) Trial
35. Local intramural delivery of low molecular weight heparin during coronary stent implantation: Preliminary report
36. Local delivery infusion pressure is a key determinant of vascular damage and intimal thickening
37. Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method
38. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group
39. One-year follow-up of the Stent Restenosis (STRESS I) Study
40. Vessel size and long-term outcome after coronary stent placement
41. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigators
42. Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: Pharmacokinetics and effect on platelet deposition in the porcine model
43. Quantification of horseradish peroxidase delivery into the arterial wall in vivo as a model of local drug treatment: Comparison between a porous and a gel-coated balloon catheter
44. Localized delivery of heparin to angio-plasty sites with iontophoresis
45. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries: The role of heparinsensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation
46. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
47. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries
48. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy